Immunome (IMNM) Net Margin (2023 - 2025)

Immunome (IMNM) reported Net Margin of 1157.61% for Q2 2025, up 53482.0% on a YoY basis from N/an in Q2 2024, and up 24.12% quarter-over-quarter from 1525.5% in Q1 2025.

Immunome (IMNM) Net Margin (2023 - 2025) Analysis & Trends

Immunome has reported Net Margin for 3 years, with the latest figure at 1157.61% in Q2 2025.

  • For the quarter ending Q2 2025, Net Margin rose 53482.0% year-over-year to 1157.61%; the trailing twelve-month figure through Mar 2026 stood at 5947.9% (down 395359.0% YoY), and the FY2025 full-year result was 3228.83%, up 15354.0% from the prior year.
  • Net Margin for Q2 2025 stood at 1157.61%, up from 1525.5% in the prior quarter.
  • The five-year high for Net Margin was 121.88% in Q3 2023, with the low at 12857.05% in Q1 2024.
  • Historically, Net Margin has averaged 2486.66% across 3 years, with a median of 1608.96% in 2025.
  • Annual changes were most pronounced in 2024 — Net Margin plunged 1266792 bps — and 2025, when it surged 1133155 bps.
  • Immunome's Net Margin stood at 2421.17% in 2023, then decreased by 25 bps to 3030.31% in 2024, then soared by 62 bps to 1157.61% in 2025.
  • The last three Net Margin figures came in at 1157.61% (Q2 2025), 1525.5% (Q1 2025), and 3030.31% (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Immunome 2.12 Bn 1.54 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,157.61%
Mar 31, 2025 -1,525.50%
Dec 31, 2024 -3,030.31%
Sep 30, 2024 -1,736.15%
Jun 30, 2024 -1,692.43%
Mar 31, 2024 -12,857.05%
Dec 31, 2023 -2,421.17%
Sep 30, 2023 -121.88%
Jun 30, 2023 -135.42%
Mar 31, 2023 -189.13%